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Acceptance is associated with lower levels of pain,
disability and psychological distress.
These treatment strategies are simple to under-
stand; however, they present a difficult, sliding
wall for both the doctor and the patient to maneu-
ver. We are still in a time when FM is not recog-
nized as a diagnosable illness, and some patients
continue to try a variety of different treatments
without success or, worse, without knowing ex-
actly why they have pain or the myriad associated
symptoms. For this reason, educating health per-
sonnel, both general practitioners and specialists,
about the concept of FM is an important first step.
Who are the best specialists to care for these pa-
tients? We do not think there is a specific special-
ty for FM; however, doctors who are skilled in
identifying and managing FM must be available
for patients. 
Therefore, the second step would be to develop
pain centers that focus on chronic, nonmalignant
pain disorders to treat these patients properly.
Rheumatologists could constitute, in most cases,
the best referring physicians for these patients;
however, pain specialists, neurologists, and physi-
atrists could refer similarly - it is less a matter of
label than of clinical and psychological skill and
attitude (4). Moreover, chronic central pain must
become a specific topic of study in graduate and
post-graduate medical school programs. The clin-
ician and the patient must work together closely to
identify the combination of treatment options and
medications that are most beneficial for that pa-
tient. Patient education is crucial so that patients
who understand their medical condition will be
able to manage their symptoms more effectively.
Through further research and education, FM pa-
tients and their families can improve their quality
of life. 
Fibromyalgia (FM), a poorly-understood chron-ic condition, is characterized by widespread
musculoskeletal pain, fatigue, non-restorative
sleep, psychological distress, and specific regions
of localized tenderness, all in the absence of oth-
erwise apparent organic disease (1). 
While the etiology of FM is unclear, accumulating
data suggests that disordered central pain process-
ing likely plays a role in the pathogenesis of symp-
toms (2). Although various pharmacological treat-
ments have been studied for treating FM, no single
drug or group of drugs has proved to be particularly
useful in treating FM patients as a whole; and to
date, only two drugs (pregabalin and duloxetine)
have earned U.S. Food and Drug Administration
(FDA) approval for treating the syndrome in the
United States (USA) (3, 4). 
Obviously, pharmacology is only one piece of the
puzzle when it comes to successful management of
FM (5, 6).
Appropriate and sensitive diagnostic methods and
a multi-faceted treatment plan including proper pa-
tient education, aerobic exercise, and cognitive-be-
havioural therapy have been shown to be effective
in alleviating FM symptoms (6,7).Within the past
20 years, cognitive-behavioural pain management
models have moved beyond the traditional focus on
coping strategies and perceived control over pain
to incorporate mindfulness - and acceptance - based
approaches (8).
Pain acceptance is the process of giving up the
struggle with pain and learning to live life despite
pain. 
2 P. Sarzi-Puttini et al.
The meeting held in Rome in February 2008 was
the first gathering of health professionals from dif-
ferent specialties within the field of FM in Italy.
Three international experts joined us for this occa-
sion and gave a strong contribution to this suc-
cessful expert consensus. 
The papers produced in this supplement represent
the outcome of this meeting and should constitute,
according to the participants, the first Italian con-
sensus specific to FM.
There is still a long road ahead, one that requires
good physicians and health care personnel, but it
also requires assistance from the health care sys-
tem, which must contribute resources to this syn-
drome. In the next few years, we expect official
recognition of this syndrome and therapeutic strate-
gies to be delivered through the national health care
system. The patient association is also growing,
and we know that this association is valuable for
its political strength. 
In conclusion, we need to reshape the pain per-
ception of our FM patients and the perception of
health care personnel toward patients. Moreover,
we need to give patients the chance to be treated
properly; none of these patients should be ignored
or left to face such an invisible and debilitating dis-
ease without help.
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